Actively Recruiting
TTE Improves Clinical Management of Stable Chest Pain
Led by Tianjin Chest Hospital · Updated on 2025-07-18
50000
Participants Needed
1
Research Sites
834 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigator aims to prospectively enroll patients who were referred for transthorcic echocardiography (TTE) for the assessment of stable chest pain (SCP) suspected of obstructive coronary artery disease (CAD). All patients underwent TTE according to established guidelines and local institutional protocols. This study will determine if TTE-based imaging evaluation can provide more informaton to improve clinical management for SCP, including fewer MACE and better decision-making of downstream investigations and therapeutic interventions.
CONDITIONS
Official Title
TTE Improves Clinical Management of Stable Chest Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Symptomatic patients with stable chest pain suspected of obstructive coronary artery disease
- Referred for transthoracic echocardiography for assessment of stable chest pain
- 18 years of age or older
- Signed informed consent
You will not qualify if you...
- Acute coronary syndromes
- Previous coronary artery disease or coronary revascularization
- Nonsinus heart rhythm
- Cardiomyopathy, valvular disease, congenital heart disease, or left heart failure from other causes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tianjin Chest Hospital
Tianjin, China
Actively Recruiting
Research Team
J
Jia Zhou
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here